Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001226966 | SCV001399299 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2023-08-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002447141 | SCV002734740 | uncertain significance | Cardiovascular phenotype | 2022-10-17 | criteria provided, single submitter | clinical testing | The p.G763S variant (also known as c.2287G>A), located in coding exon 18 of the JAG1 gene, results from a G to A substitution at nucleotide position 2287. The glycine at codon 763 is replaced by serine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |